OmniComm Systems, Inc.

FT. LAUDERDALE, FL--(MARKET WIRE)--Mar 22, 2006 -- OmniComm Systems, Inc. (OTC BB:OMCM.OB - News), one of the fastest growing companies in the EDC marketplace, announced today that the company's TrialMaster EDC product has been selected by Columbia University's International Center for Health Outcomes and Innovative Research (InCHOIR) as part of a $17 Million National Institutes of Health (NIH) sponsored Specialized Centers of Clinically Oriented Research (SCCOR) grant entitled Biology of Human Long-term Mechanical Circulatory Support. TrialMaster will be used in six SCCOR studies involving infection and coagulation surveillance, and cell therapy.

Comment - Interesting Announcement. The Company should defintely expand on what this means in terms of dollars and sense.